These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 22862827)

  • 1. Aprepitant versus ondansetron in preoperative triple-therapy treatment of nausea and vomiting in neurosurgery patients: study protocol for a randomized controlled trial.
    Bergese S; Viloria A; Uribe A; Antor A; Fernandez S
    Trials; 2012 Aug; 13():130. PubMed ID: 22862827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis.
    Weibel S; Rücker G; Eberhart LH; Pace NL; Hartl HM; Jordan OL; Mayer D; Riemer M; Schaefer MS; Raj D; Backhaus I; Helf A; Schlesinger T; Kienbaum P; Kranke P
    Cochrane Database Syst Rev; 2020 Oct; 10(10):CD012859. PubMed ID: 33075160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aprepitant for antiemesis after laparoscopic gynaecological surgery: A randomised controlled trial.
    Ham SY; Shim YH; Kim EH; Son MJ; Park WS; Lee JS
    Eur J Anaesthesiol; 2016 Feb; 33(2):90-5. PubMed ID: 26694939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Prospective, Randomized, Double-Blinded, Double-Dummy Pilot Study to Assess the Preemptive Effect of Triple Therapy with Aprepitant, Dexamethasone, and Promethazine versus Ondansetron, Dexamethasone and Promethazine on Reducing the Incidence of Postoperative Nausea and Vomiting Experienced by Patients Undergoing Craniotomy Under General Anesthesia.
    Bergese SD; Puente EG; Antor MA; Viloria AL; Yildiz V; Kumar NA; Uribe AA
    Front Med (Lausanne); 2016; 3():29. PubMed ID: 27458584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The oral neurokinin-1 antagonist aprepitant for the prevention of chemotherapy-induced nausea and vomiting: a multinational, randomized, double-blind, placebo-controlled trial in patients receiving high-dose cisplatin--the Aprepitant Protocol 052 Study Group.
    Hesketh PJ; Grunberg SM; Gralla RJ; Warr DG; Roila F; de Wit R; Chawla SP; Carides AD; Ianus J; Elmer ME; Evans JK; Beck K; Reines S; Horgan KJ;
    J Clin Oncol; 2003 Nov; 21(22):4112-9. PubMed ID: 14559886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized study of aprepitant, ondansetron and dexamethasone for chemotherapy-induced nausea and vomiting in Chinese breast cancer patients receiving moderately emetogenic chemotherapy.
    Yeo W; Mo FK; Suen JJ; Ho WM; Chan SL; Lau W; Koh J; Yeung WK; Kwan WH; Lee KK; Mok TS; Poon AN; Lam KC; Hui EK; Zee B
    Breast Cancer Res Treat; 2009 Feb; 113(3):529-35. PubMed ID: 18327706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aprepitant plus ondansetron compared with ondansetron alone in reducing postoperative nausea and vomiting in ambulatory patients undergoing plastic surgery.
    Vallejo MC; Phelps AL; Ibinson JW; Barnes LR; Milord PJ; Romeo RC; Williams BA; Sah N
    Plast Reconstr Surg; 2012 Feb; 129(2):519-526. PubMed ID: 21987042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single-dose aprepitant vs ondansetron for the prevention of postoperative nausea and vomiting: a randomized, double-blind phase III trial in patients undergoing open abdominal surgery.
    Diemunsch P; Gan TJ; Philip BK; Girao MJ; Eberhart L; Irwin MG; Pueyo J; Chelly JE; Carides AD; Reiss T; Evans JK; Lawson FC;
    Br J Anaesth; 2007 Aug; 99(2):202-11. PubMed ID: 17540667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishing the dose of the oral NK1 antagonist aprepitant for the prevention of chemotherapy-induced nausea and vomiting.
    Chawla SP; Grunberg SM; Gralla RJ; Hesketh PJ; Rittenberg C; Elmer ME; Schmidt C; Taylor A; Carides AD; Evans JK; Horgan KJ
    Cancer; 2003 May; 97(9):2290-300. PubMed ID: 12712486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ondansetron/promethazine combination or promethazine alone reduces nausea and vomiting after middle ear surgery.
    Khalil S; Philbrook L; Rabb M; Wells L; Aves T; Villanueva G; Amhan M; Chuang AZ; Lemak NA
    J Clin Anesth; 1999 Nov; 11(7):596-600. PubMed ID: 10624646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Addition of the neurokinin 1 receptor antagonist aprepitant to standard antiemetic therapy improves control of chemotherapy-induced nausea and vomiting. Results from a randomized, double-blind, placebo-controlled trial in Latin America.
    Poli-Bigelli S; Rodrigues-Pereira J; Carides AD; Julie Ma G; Eldridge K; Hipple A; Evans JK; Horgan KJ; Lawson F;
    Cancer; 2003 Jun; 97(12):3090-8. PubMed ID: 12784346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of the combination of aprepitant and dexamethasone versus the combination of ondansetron and dexamethasone for the prevention of postoperative nausea and vomiting in patients undergoing craniotomy.
    Habib AS; Keifer JC; Borel CO; White WD; Gan TJ
    Anesth Analg; 2011 Apr; 112(4):813-8. PubMed ID: 21081776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of nausea and vomiting associated with stem cell transplant: results of a prospective, randomized trial of aprepitant used with highly emetogenic preparative regimens.
    Stiff PJ; Fox-Geiman MP; Kiley K; Rychlik K; Parthasarathy M; Fletcher-Gonzalez D; Porter N; Go A; Smith SE; Rodriguez TE
    Biol Blood Marrow Transplant; 2013 Jan; 19(1):49-55.e1. PubMed ID: 22863840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The combination of haloperidol, dexamethasone, and ondansetron for prevention of postoperative nausea and vomiting in laparoscopic sleeve gastrectomy: a randomized double-blind trial.
    Benevides ML; Oliveira SS; de Aguilar-Nascimento JE
    Obes Surg; 2013 Sep; 23(9):1389-96. PubMed ID: 23529851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Role of Aprepitant in Prevention of Postoperative Nausea and Vomiting After Bariatric Surgery.
    Therneau IW; Martin EE; Sprung J; Kellogg TA; Schroeder DR; Weingarten TN
    Obes Surg; 2018 Jan; 28(1):37-43. PubMed ID: 28674839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aprepitant's prophylactic efficacy in decreasing postoperative nausea and vomiting in morbidly obese patients undergoing bariatric surgery.
    Sinha AC; Singh PM; Williams NW; Ochroch EA; Goudra BG
    Obes Surg; 2014 Feb; 24(2):225-31. PubMed ID: 23990451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dexamethasone plus ondansetron for prevention of postoperative nausea and vomiting in patients undergoing laparoscopic cholecystectomy: a comparison with dexamethasone alone.
    Bano F; Zafar S; Aftab S; Haider S
    J Coll Physicians Surg Pak; 2008 May; 18(5):265-9. PubMed ID: 18541078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of a disposable acupressure device as part of a multimodal antiemetic strategy for reducing postoperative nausea and vomiting.
    White PF; Zhao M; Tang J; Wender RH; Yumul R; Sloninsky AV; Naruse R; Kariger R; Cunneen S
    Anesth Analg; 2012 Jul; 115(1):31-7. PubMed ID: 22504214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized, double-blind, multicenter trial comparing transdermal scopolamine plus ondansetron to ondansetron alone for the prevention of postoperative nausea and vomiting in the outpatient setting.
    Gan TJ; Sinha AC; Kovac AL; Jones RK; Cohen SA; Battikha JP; Deutsch JS; Pergolizzi JV; ; Glass PS
    Anesth Analg; 2009 May; 108(5):1498-504. PubMed ID: 19372328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alizapride and ondansetron for the prevention of postoperative nausea and vomiting in patients undergoing laparoscopic gynaecological surgery: A double-blind, randomised, placebo-controlled noninferiority study.
    Dewinter G; Teunkens A; Vermeulen K; Devroe S; Van Hemelrijck J; Meuleman C; Vergote I; Fieuws S; Van de Velde M; Rex S
    Eur J Anaesthesiol; 2016 Feb; 33(2):96-103. PubMed ID: 26086285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.